Director dealing and issue of equity

RNS Number : 5756E

Deltex Medical Group PLC

12 February 2018

 

12 February 2018

Deltex Medical Group plc

("Deltex Medical", "Deltex" or "the Company")

Director dealing and issue of equity

Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring ("ODM") announces that it has issued 800,000 new Ordinary Shares of 1 pence each in the capital of the Company ("Ordinary Shares") in connection with the exercise of options by Ewan Phillips, Chief Executive Officer, granted under the Company's Enterprise Management Incentive Share Option Scheme. The options had an exercise price of 1 pence per share and the notice of exercise was received on 9 February 2018.

Application has been made for the 800,000 new Ordinary Shares to be admitted to trading on AIM ("Admission"), and dealings are expected to commence on 15 February 2018. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

Following Admission, the total number of Ordinary Shares in issue with voting rights will be  490,663,367 Ordinary Shares. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Confirmation of Director's shareholding

Following the above purchase, Ewan Phillips owns 4,682,111 ordinary shares representing 0.95% per cent. of the Company's issued share capital.

For further information, please contact:-

Deltex Medical Group plc	01243 774 837 [e-mail]
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Jonathan Shaw, Group Finance Director
Nominated Adviser & Broker
Arden Partners plc	020 7614 5900
Chris Hardie Ciaran Walsh
Joint Broker
Turner Pope Investments (TPI) Ltd	0203 621 4120 [e-mail]
Andy Thacker
Financial Public Relations
IFC Advisory Ltd	0203 053 8671
Tim Metcalfe Graham Herring Heather Armstrong

PDMR Notification Forms:

The notifications below are made in accordance with the requirements of MAR.

1.	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Ewan Phillips
2.	Reason for the Notification
a)	Position/status	Chief Executive
b)	Initial notification/amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Deltex Medical Group plc
b)	LEI	N/A
4.	Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted
a)	Description of the Financial instrument, type of instrument	Ordinary shares of 1 pence each
	Identification code	GB00B95L0551
b)	Nature of the Transaction	Exercise of share options
c)	Price(s) and volume(s)	Price(s) Volume(s) 1p 800,000
d)	Aggregated information Aggregated volume Price	N/A (Single transaction)
e)	Date of the transaction	15 February 2018
f)	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

DSHLIFFAFSIFLIT